211 related articles for article (PubMed ID: 29469204)
1. Plasma ammonia concentration after L-asparaginase therapy in 27 dogs with high-grade lymphoma or leukemia.
Speas AL; Lyles SE; Wirth KA; Fahey CE; Kow K; Lejeune AT; Milner RJ
J Vet Emerg Crit Care (San Antonio); 2018 Mar; 28(2):130-139. PubMed ID: 29469204
[TBL] [Abstract][Full Text] [Related]
2. Transient hyperammonemia due to L-asparaginase therapy in children with acute lymphoblastic leukemia or non-Hodgkin lymphoma.
Jörck C; Kiess W; Weigel JF; Mütze U; Bierbach U; Beblo S
Pediatr Hematol Oncol; 2011 Feb; 28(1):3-9. PubMed ID: 20615069
[TBL] [Abstract][Full Text] [Related]
3. Acute hyperammonemia after L-asparaginase administration in a dog.
Lyles SE; Kow K; Milner RJ; Buckley GJ; Bandt C; Baxter KJ
J Vet Emerg Crit Care (San Antonio); 2011 Dec; 21(6):673-8. PubMed ID: 22316261
[TBL] [Abstract][Full Text] [Related]
4. Neutropenia associated with vincristine and L-asparaginase induction chemotherapy for canine lymphoma.
Northrup NC; Rassnick KM; Snyder LA; Stone MS; Kristal O; Cotter SM; Moore AS
J Vet Intern Med; 2002; 16(5):570-5. PubMed ID: 12322708
[TBL] [Abstract][Full Text] [Related]
5. Distinct fluctuations of ammonia levels during asparaginase therapy for childhood acute leukemia.
Steiner M; Attarbaschi A; Kastner U; Dworzak M; Haas OA; Gadner H; Mann G
Pediatr Blood Cancer; 2007 Oct; 49(5):640-2. PubMed ID: 16941647
[TBL] [Abstract][Full Text] [Related]
6. Polyethylene glycol-L-asparaginase versus native L-asparaginase in canine non-Hodgkin's lymphoma.
Teske E; Rutteman GR; van Heerde P; Misdorp W
Eur J Cancer; 1990; 26(8):891-5. PubMed ID: 2145933
[TBL] [Abstract][Full Text] [Related]
7. Acute central nervous system complications and ammonium levels in adult patients with acute lymphoblastic leukemia receiving l-asparaginase.
Strickler N; Balabanov S; Casauro K; Schanz U; Manz MG; Gerber B
Leuk Lymphoma; 2018 Apr; 59(4):855-862. PubMed ID: 28728499
[TBL] [Abstract][Full Text] [Related]
8. Concurrent use of rabacfosadine and L-asparaginase for relapsed or refractory multicentric lymphoma in dogs.
Cawley JR; Wright ZM; Meleo K; Post GS; Clifford CA; Vickery KR; Vail DM; Bergman PJ; Thamm DH
J Vet Intern Med; 2020 Mar; 34(2):882-889. PubMed ID: 32064697
[TBL] [Abstract][Full Text] [Related]
9. The ex vivo production of ammonia predicts L-asparaginase biological activity in children with acute lymphoblastic leukemia.
Watanabe S; Miyake K; Ogawa C; Matsumoto H; Yoshida K; Hirabayashi S; Hasegawa D; Inoue T; Kizu J; Machida R; Ohara A; Hosoya R; Manabe A
Int J Hematol; 2009 Oct; 90(3):347-352. PubMed ID: 19768519
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and adverse events of continuous l-asparaginase administration for canine large cell lymphoma of presumed gastrointestinal origin.
Nakagawa T; Kojima M; Ohno K; Chambers JK; Uchida K; Ohmi A; Goto-Koshino Y; Tomiyasu H; Tsujimoto H
Vet Comp Oncol; 2022 Mar; 20(1):102-108. PubMed ID: 34213084
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of L-asparaginase induced elevation of blood ammonia and hepatic encephalopathy].
Li Y; Ren HY; Cen XN; Yin Y; Liang ZY
Zhonghua Xue Ye Xue Za Zhi; 2013 Jul; 34(7):578-80. PubMed ID: 23906449
[TBL] [Abstract][Full Text] [Related]
12. Clinical utility of ammonia concentration as a diagnostic test in monitoring of the treatment with L-asparaginase in children with acute lymphoblastic leukemia.
Czogała M; Balwierz W; Sztefko K; Rogatko I
Biomed Res Int; 2014; 2014():945860. PubMed ID: 25157375
[TBL] [Abstract][Full Text] [Related]
13. L-asparaginase for treatment of lymphoid neoplasia in dogs.
Rogers KS
J Am Vet Med Assoc; 1989 Jun; 194(11):1626-30. PubMed ID: 2568982
[No Abstract] [Full Text] [Related]
14. Prospective evaluation of the safety of compounded bulk material L-asparaginase in dogs with lymphoma.
Thiman J; Northrup N; Saba C; Clarke D; Regan R; Hamilton T; Lindell H; Hofmeister E
J Vet Pharmacol Ther; 2016 Dec; 39(6):572-577. PubMed ID: 27086733
[TBL] [Abstract][Full Text] [Related]
15. Proof-of-concept study: Evaluation of plasma and urinary electrolytes as markers of response to L-asparaginase therapy in dogs with high-grade lymphoma.
Sayag D; Chamel G; Bédard C; Beauchamp G; Couturier S; Ponce F; Rannou B
Vet Clin Pathol; 2020 Sep; 49(3):476-483. PubMed ID: 32955128
[TBL] [Abstract][Full Text] [Related]
16. High efficacy of monomethoxypolyethylene glycol-conjugated L-asparaginase (PEG2-ASP) in two patients with hematological malignancies.
Kawashima K; Takeshima H; Higashi Y; Hamaguchi M; Sugie H; Imamura I; Wada H
Leuk Res; 1991; 15(6):525-30. PubMed ID: 1861535
[TBL] [Abstract][Full Text] [Related]
17. [Update on L-asparaginase treatment in paediatrics].
Moscardó Guilleme C; Fernández Delgado R; Sevilla Navarro J; Astigarraga Aguirre I; Rives Solà S; Sánchez de Toledo Codina J; Fuster Soler JL; Parra Ramirez L; Molina Garicaño J; González Martínez B; Madero López L
An Pediatr (Barc); 2013 Nov; 79(5):329.e1-329.e11. PubMed ID: 23727426
[TBL] [Abstract][Full Text] [Related]
18. Does L-asparaginase influence efficacy or toxicity when added to a standard CHOP protocol for dogs with lymphoma?
MacDonald VS; Thamm DH; Kurzman ID; Turek MM; Vail DM
J Vet Intern Med; 2005; 19(5):732-6. PubMed ID: 16231719
[TBL] [Abstract][Full Text] [Related]
19. Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l-asparaginase: The GRAALL experience.
Couturier MA; Huguet F; Chevallier P; Suarez F; Thomas X; Escoffre-Barbe M; Cacheux V; Pignon JM; Bonmati C; Sanhes L; Bories P; Daguindau E; Dorvaux V; Reman O; Frayfer J; Orvain C; Lhéritier V; Ifrah N; Dombret H; Hunault-Berger M; Tanguy-Schmidt A
Am J Hematol; 2015 Nov; 90(11):986-91. PubMed ID: 26214580
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of PEG-L-asparaginase in asparagine suppression and anti-drug antibody development in healthy Beagle dogs: A multi-phase preclinical study.
Feenstra LR; Gehring R; van Geijswijk IM; König T; Prinsen HCMT; Vandemeulebroecke K; Lammens T; Krupa A; Teske E
Vet J; 2022 Aug; 286():105854. PubMed ID: 35781075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]